A field manual for the new longevity — deep protocol reporting, first-person cycles, and zero supplement-influencer noise. Written by practitioners for practitioners, the week the molecules went legal.
Mechanism is not outcome. Animal data is not human data. Commercial claims are not studies. A framework for reading peptide research clearly.
Three categories of skin peptides exist. They have different evidence bases, different mechanisms, and almost no one selling them wants you to know the difference.
GHK-Cu resets tissue repair signaling. The debate isn't whether it works — it's whether topical application gets it where it needs to go.
A protocol-first guide for first-time peptide users. Covers compound selection, dosing frameworks, cycle structure, and the safety considerations most beginners miss.
Peptides are short chains of amino acids that your body already uses to run itself. Here's what they are, how they work, and why they matter now.
A first-person account of running BPC-157 for a partial rotator cuff tear — what the research predicted, what actually happened, and where the two diverged.
Mid-cycle, the phone started vibrating. The April 15 HHS action — Secretary Robert F. Kennedy Jr. directing the FDA to remove twelve compounds from Category…
One long dispatch every Sunday. Protocol updates when we’re running one. Field notes when we’re not. No promotions, no “5 supplements that changed my life,” no cross-promotion with anyone trying to sell you pills. You can leave whenever you like.